Last reviewed · How we verify
ClinSupV3 -soft gelatin capsule
ClinSupV3 is a soft gelatin capsule used to treat various conditions.
ClinSupV3 is a soft gelatin capsule used to treat various conditions. Used for Gastroesophageal reflux disease (GERD), Peptic ulcer disease.
At a glance
| Generic name | ClinSupV3 -soft gelatin capsule |
|---|---|
| Also known as | Clindamycin plus Clotrimazole |
| Sponsor | Dr Bharti Daswani |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Mechanism of action
The exact mechanism of action of ClinSupV3 is not well-documented, but it is believed to work by affecting the body's response to certain conditions.
Approved indications
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease
Common side effects
- Nausea
- Headache
- Diarrhea
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ClinSupV3 -soft gelatin capsule CI brief — competitive landscape report
- ClinSupV3 -soft gelatin capsule updates RSS · CI watch RSS
- Dr Bharti Daswani portfolio CI